Immunomodulatory effects of licochalcone A on experimental autoimmune encephalomyelitis

Journal of Pharmacy and Pharmacology

Volumn 66, Issue 6, 2014, Pages 886-894

  Fontes, Lívia Beatriz Almeida ^a   Dos Santos Dias, Débora ^a   De Carvalho, Lara Soares Aleixo ^a   Mesquita, Harleson Lopes ^b   Da Silva Reis, Lívia ^a   Dias, Alyria Teixeira ^a   Da Silva Filho, Ademar A ^a   Do Amaral Corrêa, José Otávio ^a  

^a FEDERAL UNIVERSITY OF JUIZ DE FORA   (Brazil)

^b Division of Anesthesiology   (Brazil)

Author keywords

cytokines; experimental autoimmune encephalomyelitis; immunomodulation; multiple sclerosis; natural products

Indexed keywords

CONCANAVALIN A; GAMMA INTERFERON; HYDROGEN PEROXIDE; INTERLEUKIN 17; LICOCHALCONE A; NITRIC OXIDE; TUMOR NECROSIS FACTOR ALPHA; CHALCONE DERIVATIVE; CYTOKINE; IMMUNOLOGIC FACTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DRUG EFFICACY; DRUG ISOLATION; DRUG RESEARCH; DRUG STRUCTURE; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; FEMALE; GLYCYRRHIZA; GLYCYRRHIZA INFLATA; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PERITONEUM CELL; PLANT ROOT; SPLEEN CELL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; IMMUNOLOGY;

ANIMALS; CHALCONES; CYTOKINES; ENCEPHALOMYELITIS, AUTOIMMUNE, EXPERIMENTAL; FEMALE; IMMUNOLOGIC FACTORS; MICE; MICE, INBRED C57BL; NITRIC OXIDE;

EID: 84900488142     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/jphp.12212     Document Type: Article

References (32)

1. Sheremata WM, Tornes L,. Multiple sclerosis and the spinal cord. Neurol Clin 2013; 31: 55-77.
2. Berto P, et al. The direct cost of patients with multiple sclerosis: a survey from Italian MS centres. Neurol Sci 2011; 32: 1035-1041.
3. Chen X, et al. Attenuation of experimental autoimmune encephalomyelitis in C57 Bl/6 mice by osthole, a natural coumarin. Eur J Pharmacol 2010; 629: 40-46.
4. Corrêa JOA, et al. Effect of thalidomide and pentoxifylline on experimental autoimmune encephalomyelitis (EAE). Exp Neurol 2010; 226: 15-23.
5. Lassmann H,. Pathophysiology of inflammation and tissue injury in multiple sclerosis: what are the targets for therapy. J Neurol Sci 2011; 306: 167-169.
6. Mix E, et al. Animal models of multiple sclerosis for the development and validation of novel therapies-potential and limitations. J Neurol 2008; 255: 7-14.
7. Rodgers JM, Miller SD,. Cytokine control of inflammation and repair in the pathology of multiple sclerosis. Yale J Biol Med 2012; 85: 447-468.
8. Newman DJ, Cragg GM,. Natural products as sources of new drugs over the 30 years from 1981 to 2010. J Nat Prod 2012; 75: 311-335.
9. Da Silva Filho AA, et al. In vitro trypanocidal activity evaluation of crude extract and isolated compounds from Baccharis dracunculifolia D.C. (Asteraceae). J Pharm Pharmacol 2004; 56: 1195-1199a.
10. Barfod L, et al. Chalcones from Chinese liquorice inhibit proliferation of T cells and production of cytokines. Int Immunopharmacol 2002; 2: 545-555.
11. Zhou L, et al. IL-6 programs T (H)-17 cell differentiation by promoting sequential engagement of the IL-21 and IL-23 pathways. Nat Immunol 2007; 8: 967-974.
12. Chu X, et al. Licochalcone A inhibits lipopolysaccharide-induced inflammatory response in vitro and in vivo. J Agric Food Chem 2012; 60: 3947-3954.
13. Furusawa JI, et al. Licochalcone A significantly suppresses LPS signaling pathway through the inhibition of NF-κB p65 phosphorylation at serine 276. Cell Signal 2009; 21: 778-785a.
14. Funakoshi-Tago M, et al. Licochalcone A is a potent inhibitor of TEL-Jak2-mediated transformation through the specific inhibition of Stat3 activation. Biochem Pharmacol 2008; 76: 1681-1693.
15. Da Silva Filho AA, et al. Evaluation of analgesic and anti-inflammatory activities of Nectandra megapotamica (Lauraceae) in mice and rats. J Pharm Pharmacol 2004; 56: 1179-1184b.
16. Missima F, et al. Effect of Baccharis dracunculifolia D. C. (Asteraceae) extracts and its isolated compounds on macrophage activation. J Pharm Pharmacol 2007; 59: 463-468.
17. Wang Q, et al. Isolation and purification of inflacoumarin A and licochalcone A from licorice by high-speed counter-current chromatography. J Chromatogr A 2004; 1048: 51-57.
18. Castro SBR, et al. Immunomodulatory effects and improved prognosis of experimental autoimmune encephalomyelitis after O-tetradecanoyl-genistein treatment. Int Immunopharmacol 2012; 12: 465-470.
19. Alves CCS, et al. Anthraquinone derivative O.O′- bis-(3′- iodopropyl)-1,4-dihidroxyanthraquinone modulates immune responses and improves experimental autoimmune encephalomyelitis. Int Immunopharmacol 2012; 14: 127-132.
20. Peron JPS, et al. Oral tolerance reduces Th17 cells as well as the overall inflammation in the central nervous system of EAE mice. J Neuroimmunol 2010; 227: 10-17.
21. Kim HI, et al. Antiangiogenic effect of licochalcone A. Biochem Pharmacol 2010; 80: 1152-1159.
22. Pick E, Mizel D,. Rapid microassays for the measurement of superoxide and hydrogen peroxide production by macrophage in culture using an automatic enzyme immunoassay reader. J Immunol Methods 1981; 46: 211-226.
23. Green LC, et al. Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 1982; 126: 131-138.
24. Dutra RC, et al. Euphol prevents experimental autoimmune encephalomyelitis in mice: evidence for the underlying mechanisms. Biochem Pharmacol 2012; 83: 531-542.
25. Linker RA, et al. Fumaric acid esters exert neuroprotective effects in neuroinflammation via activation of the Nrf2 antioxidant pathway. Brain 2010; 34: 678-692.
26. Leiper J, et al. The therapeutic potential of targeting endogenous inhibitors of nitric oxide synthesis. Nat Rev Drug Discov 2011; 10: 277-291.
27. Lee E, et al. IFN-gamma signaling in the central nervous system controls the course of experimental autoimmune encephalomyelitis independently of the localization and composition of inflammatory foci. J Neuroinflammation 2012; 16: 9-7.
28. Wang X, et al. Roles of T helper 17 cells and interleukin-17 in neuroautoimmune diseases with emphasis on multiple sclerosis and Guillain-Barre syndrome as well as their animal models. J Neurosci Res 2013; 91: 871-881.
29. Funakoshi-Tago M, et al. Licochalcone A potently inhibits tumor necrosis factor-induced Nuclear Factor-κB activation through the direct inhibition of IB kinase complex activation. Mol Pharmacol 2009; 76: 745-753.
30. Komiyama Y, et al. IL-17 plays an important role in the development of experimental autoimmune encephalomyelitis. J Immunol 2006; 177: 566-573.
31. Achiron A, et al. Dexanabinol (HU-211) effect on experimental autoimmune encephalomyelitis: implications for the treatment of acute relapses of multiple sclerosis. J Neuroimmunol 2000; 102: 26-31.
32. Murta V, Ferrari CC,. Influence of Peripheral inflammation on the progression of multiple sclerosis: evidence from the clinic and experimental animal models. Mol Cell Neurosci 2013; 53: 6-13.